Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab-Reference-Cited by-同舟云学术

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

Published:2012-04-22 Issue:1 Volume:60 Page:101-109
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Marsh Rebecca A.,Allen Carl E.,McClain Kenneth L.,Weinstein Joanna L.,Kanter Julie,Skiles Jodi,Lee Nadine D.,Khan Shakila P.,Lawrence Julia,Mo Jun Q.,Bleesing Jack J.,Filipovich Alexandra H.,Jordan Michael B.

Funder

NIH

Clinical Immunology Society

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24188/fullpdf

Reference21 articles.

1. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation;Henter;Blood,2002

2. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis;Henter;Pediatr Blood Cancer,2007

3. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: A single-center retrospective report of 38 patients;Mahlaoui;Pediatrics,2007

5. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis;Horne;Br J Haematol,2005

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Features, Treatment, and Outcomes of Nivolumab-Induced Hemophagocytic Lymphohistiocytosis;Journal of Immunotherapy;2024-08-26

2. Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients;Annals of Hematology;2024-07-30

3. Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy;Seminars in Immunopathology;2024-07-16

4. Infection-associated hemophagocytic lymphohistiocytosis: a case report;Annals of Medicine & Surgery;2024-07-01

5. Cytomegalovirus infection risk with alemtuzumab therapy in hematological malignancies: a retrospective cohort study in the non-transplant setting;Leukemia & Lymphoma;2024-07